CAMBRIDGE, England & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer ® and pre|CISION™ ...

CAMBRIDGE, England--(BUSINESS WIRE)--Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has ...

(RTTNews) - Avacta Group plc (AVCT.L), a developer of Affimer biotherapeutics and reagents, announced Monday that it has entered into a license agreement with Astrea Bioseparations for the use of the ...

Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a ...

MENLO PARK, Calif., Feb. 15, 2023 /PRNewswire/ -- Gamma Biosciences ("Gamma"), a global life sciences platform formed by KKR to address the advanced therapy market with best-in-class bioprocessing ...

Astrea Bioseparations Ltd (formerly Prometic Bioseparations Ltd) has long been established as an expert in affinity chromatography and bioseparations. Providing services for ligand design, adsorbent ...

(RTTNews) - Gamma Biosciences, a life sciences platform formed by KKR, has entered into an agreement with Biotage AB, whereby Biotage will acquire Gamma's operating company, Astrea Bioseparations, in ...

Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing. Astra Bioseparations (Astrea Bio), a provider of bioseparation and purification ...

Astrea Bioseparations (“Astrea Bio”) has announced the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology. Incorporating AstreAdept™, the Company’s proprietary ...